Miller, S;
Correia, F;
Lagrata, S;
Matharu, MS;
(2015)
OnabotulinumtoxinA for Hemicrania Continua: open label experience in 9 patients.
J Headache Pain
, 16
(1)
, Article 502. 10.1186/s10194-015-0502-z.
Preview |
PDF
s10194-015-0502-z.pdf Download (371kB) |
Abstract
Hemicrania continua is a strictly unilateral, continuous headache, typically mild to moderate in severity, with severe exacerbations commonly accompanied by cranial autonomic features and migrainous symptoms. It is exquisitely responsive to Indomethacin. However, some patients cannot tolerate treatment, often due to gastrointestinal side effects. Therapeutic alternatives are limited and controlled evidence lacking.
Type: | Article |
---|---|
Title: | OnabotulinumtoxinA for Hemicrania Continua: open label experience in 9 patients. |
Location: | Italy |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1186/s10194-015-0502-z |
Publisher version: | http://dx.doi.org/10.1186/s10194-015-0502-z |
Language: | English |
Additional information: | © 2015 Miller et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Brain Repair and Rehabilitation |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/1467000 |
Archive Staff Only
View Item |